
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ZAP70**: A tyrosine kinase involved in T-cell receptor signaling.<br>- **LCK**: A tyrosine kinase that plays a crucial role in T-cell activation.<br>- **LAT**: A linker for activation of T cells, involved in T-cell receptor signaling.<br>- **RAC2**: A small GTPase involved in the regulation of cell signaling.<br>- **IL2RG**: A common gamma chain receptor involved in cytokine signaling.<br>- **TRAF3IP3**: Involved in T-cell receptor signaling.<br>- **FYB1**: An adapter protein involved in T-cell receptor signaling.<br>- **DUSP2**: A phosphatase involved in the regulation of MAP kinase signaling pathways.<br><br>### Step 2: List the Key Cell Type Markers<br>- **CD3E, CD3D, CD3G**: Components of the CD3 complex, essential for T-cell receptor signaling, indicating T cells.<br>- **CD2**: A surface marker found on T cells and natural killer cells.<br>- **CD7**: A marker found on T cells and natural killer cells.<br>- **CD52**: A glycoprotein expressed on the surface of mature lymphocytes.<br>- **CD247 (CD3Z)**: Part of the T-cell receptor-CD3 complex.<br>- **TRBC1, TRBC2, TRAC**: T-cell receptor beta and alpha chain components, indicating T cells.<br>- **CD27**: A member of the TNF receptor family, expressed on T cells.<br>- **PTPRCAP**: Associated with T-cell activation.<br>- **CCL5**: A chemokine involved in T-cell recruitment.<br>- **IL32**: A cytokine involved in T-cell activation.<br>- **LSP1**: A protein expressed in leukocytes, including T cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas, PanglaoDB, and literature on T-cell markers, the presence of CD3 complex components (CD3E, CD3D, CD3G), T-cell receptor components (TRBC1, TRBC2, TRAC), and other T-cell markers (CD2, CD7, CD27) strongly suggest a T-cell identity.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of the CD3 complex, T-cell receptor components, and other T-cell markers, the most probable general cell type is **T cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **CD4+ T cells**: Given the presence of markers like CD3 and CD27, which are common in helper T cells.<br>2. **CD8+ T cells**: The presence of cytotoxic markers like CCL5 and RAC2 suggests cytotoxic T cells.<br>3. **Regulatory T cells (Tregs)**: Although less likely due to the absence of specific markers like FOXP3, the presence of IL2RG and CD27 could suggest a regulatory role.<br><br>The most likely subtype based on the markers is **CD4+ T cells**, as the dataset lacks specific cytotoxic markers like CD8A or CD8B, which would be more indicative of CD8+ T cells.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of T cells. The expression of key T-cell markers such as CD3E, CD3D, CD3G, and T-cell receptor components strongly supports this annotation. Among T cells, the most probable subtype is CD4+ T cells, given the presence of markers associated with helper T cells and the absence of specific cytotoxic markers.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**:<br>   - The key functional markers listed (ZAP70, LCK, LAT, RAC2, IL2RG, TRAF3IP3, FYB1, DUSP2) are present in the provided marker list.<br>   - The key cell type markers (CD3E, CD3D, CD3G, CD2, CD7, CD52, CD247, TRBC1, TRBC2, TRAC, CD27, PTPRCAP, CCL5, IL32, LSP1) are also present in the provided marker list.<br>   - The presence of these markers strongly supports the identification of T cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The analysis correctly identifies the potential for subtypes within the T-cell population, such as CD4+ T cells, CD8+ T cells, and regulatory T cells (Tregs).<br>   - The absence of specific markers for CD8+ T cells (like CD8A or CD8B) and Tregs (like FOXP3) is noted, which supports the conclusion that CD4+ T cells are the most likely subtype.<br><br>The annotation is well-supported by the marker list and the analysis provided. There is no strong evidence of mixed cell types beyond the expected T-cell subtypes, and the annotation process has been thorough and consistent with the data.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">T cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>CD4+ T cells</li><li>CD8+ T cells</li><li>Regulatory T cells (Tregs)</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided are generally well-executed, with a strong focus on identifying T cells as the main cell type, which is consistent with the marker list. The analysis correctly identifies key functional and cell type markers such as ZAP70, LCK, LAT, CD3E, CD3D, and CD3G, which are crucial for T-cell identification. The annotation process demonstrates a balanced consideration of multiple markers, rather than over-focusing on a specific one, which is a strength.<br><br>The analysis also attempts to identify subtypes within the T-cell population, such as CD4+ T cells, CD8+ T cells, and regulatory T cells (Tregs). However, the absence of specific markers for CD8+ T cells (like CD8A or CD8B) and Tregs (like FOXP3) is noted, which supports the conclusion that CD4+ T cells are the most likely subtype. This shows a good understanding of the limitations of the data and the importance of specific markers for accurate subtype identification.<br><br>One potential weakness is the lack of consideration for the rank of the markers. While the analysis identifies key markers, it does not explicitly address the importance of the order in which these markers appear in the list. The rank of markers can provide additional insights into their relative importance and should be considered in the analysis.<br><br>Overall, the annotation provides a comprehensive view of the cell types present, with no obvious misclassifications or oversights. The analysis is scientifically accurate and well-supported by the marker list, capturing the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    